ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.
Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
One of famed investor Warren Buffett's principles is to buy shares of wonderful companies at fair prices to hold for the long term. Let's try to use it to decide whether Intuitive Surgical (ISRG 1.22%
Investors searching for long-duration compounders don't need to overcomplicate things. One approach is to look for market-leading, platform-like business models with recurring economics and management
Intuitive Surgical, Inc. (ISRG) closed at $476.16 in the latest trading session, marking a +1.34% move from the prior day.
Investors have been looking at robotics companies for several decades. But artificial intelligence (AI) is taking robotics beyond basic automation by bringing more precision, flexibility, and adaptabi
The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.
Investing styles tend to evolve as people age. Seniors who are already retired often look for steady, reliable, dividend-paying companies.
Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.

Intuitive Surgical Has More Room To Grow

04:24am, Wednesday, 13'th Aug 2025
Intuitive Surgical's da Vinci system is driving strong global growth, with 17% YoY procedure growth and expanding adoption across hospitals and specialties. Recurring revenue streams from system sales
Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.
Investing in stocks is both accessible to the general public and likely to yield strong returns over the long term. That's what makes it one of the best ways to increase your wealth.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE